Table 2.
Type of thrombophilia and transient risk factors for cerebral vein thrombosis in the study population
—indicates not applicable.
*
Four patients and no control subjects had homozygous prothrombin mutation.
†
Percentage calculated on the number of patients not on oral anticoagulants at the time of blood sampling.
‡
Percentage calculated on the number of women of reproductive age.
§
Percentage calculated on the number of postmenopause women.
∥
Infections were otitis in 2 patients and meningitis in 1 patient.
